Search by Drug Name or NDC
NDC 49873-0402-01 Inon Ace 20; 60; 200 mg/1; mg/1; mg/1 Details
Inon Ace 20; 60; 200 mg/1; mg/1; mg/1
Inon Ace is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Sato Pharmaceutical Co., Ltd.. The primary component is DIMETHICONE; MAGNESIUM HYDROXIDE; SILODRATE.
Product Information
| NDC | 49873-0402 |
|---|---|
| Product ID | 49873-402_09d87d9c-fe4c-fd02-e063-6394a90a56bd |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Inon Ace |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | magnesium aluminosilicates, magnesium hydroxide, simethicone |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20; 60; 200 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | DIMETHICONE; MAGNESIUM HYDROXIDE; SILODRATE |
| Labeler Name | Sato Pharmaceutical Co., Ltd. |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M001 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49873-0402-01 (49873040201)
| NDC Package Code | 49873-402-01 |
|---|---|
| Billing NDC | 49873040201 |
| Package | 1 BOTTLE in 1 CARTON (49873-402-01) / 75 TABLET in 1 BOTTLE |
| Marketing Start Date | 1995-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |